Data timelines which jump out from this announcement.
Azer-cel: Allogeneic CAR T cell therapy
- A preliminary early data update is anticipated in the second half of 2024
VAXINIA MAST Trial
- Bile tract cancer expansion trial opened and is expected to enroll approximately 10 patients; preliminary early data is expected in the second half 2024
OnCARlytics (CF33-CD19)
- Preliminary early combination data are expected in the fourth quarter of 2024
B Cell Immunotherapy: PD1-Vaxx
- Preliminary early data are expected in 2025
Good luck to all holders brave enough to have invested patient capital.
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-23
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $387.9M |
Open | High | Low | Value | Volume |
5.1¢ | 5.3¢ | 5.0¢ | $605.4K | 11.73M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 455000 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 1913821 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 455000 | 0.051 |
33 | 3113899 | 0.050 |
25 | 2646764 | 0.049 |
20 | 1669400 | 0.048 |
13 | 1134963 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 1913821 | 7 |
0.054 | 2460442 | 7 |
0.055 | 1039326 | 12 |
0.056 | 233333 | 3 |
0.057 | 200000 | 2 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |